Knee Osteoarthritis Therapy Targeting NLRP3 Inflammasome: Progress From Mechanism to Application
Immunity, Inflammation and Disease · 2026
DOI: 10.1002/iid3.70520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, 2026. Verfasst von Wenguang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Osteoarthritis, Knee, Medicine, Chinese Traditional. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program Project of Jiangxi Provincial Administration of Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China, Education Department of Jiangxi Province.
Abstract (Originalsprache)
Objective
This paper briefly reviews the structure, function, and activation mechanism of the NLRP3 inflammasome and its molecular role in the pathogenesis of knee osteoarthritis (KOA), and explores the potential value of traditional Chinese medicine (TCM) in treating KOA by modulating NLRP3 inflammasome activity. The review covers evidence from mechanistic studies, in vitro experiments, in vivo models, and currently available clinical‐related findings.
Methods
To investigate the role of the NLRP3 inflammasome in KOA, a comprehensive literature search was conducted across multiple databases, including PubMed, MEDLINE, Web of Science, Scopus, and various Chinese biomedical repositories (CNKI, CBM, VIP, COJ). Emphasis was placed on studies published in the past 5 years concerning TCM‐based interventions targeting NLRP3 in KOA models, facilitating comparative analysis and synthesis of recent evidence.
Results
NLRP3 inflammasome has been implicated in multiple pathological processes of KOA, including cartilage degradation, inflammation of the synovium, programmed cell death (pyroptosis), and the activation of osteoclasts. Interventions using TCM—such as herbal monomers, multi‐compound formulas, external preparations, and acupuncture—can mitigate these pathological events by modulating NLRP3 activity.
Conclusion
The NLRP3 inflammasome is a critical mediator in KOA pathophysiology, influencing inflammation, cartilage deterioration, pyroptosis, and bone metabolism. Strategies derived from TCM that target this inflammasome may offer promising avenues for developing precise and effective treatments for KOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Medical College of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
- The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Förderung
- Science and Technology Program Project of Jiangxi Provincial Administration of Traditional Chinese Medicine
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Education Department of Jiangxi Province
- Advantageous Specialty Funding Project of the Affiliated Hospitital of Jiangxi University of Chinese Medicine
Zitieren
APA
Chen, W., Yi, B., Wang, Z., Yu, C., Li, Z., Wu, Z., & Hong, E. (2026). Knee Osteoarthritis Therapy Targeting NLRP3 Inflammasome: Progress From Mechanism to Application. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70520
Vancouver
Chen W, Yi B, Wang Z, Yu C, Li Z, Wu Z, et al. Knee Osteoarthritis Therapy Targeting NLRP3 Inflammasome: Progress From Mechanism to Application. Immunity, Inflammation and Disease. 2026. doi:10.1002/iid3.70520
BibTeX
@article{Chen2026,
author = {Chen, Wenguang and Yi, Baoxiu and Wang, Zhang and Yu, Cong and Li, Ziru and Wu, Zenan and Hong, Ensi},
title = {Knee Osteoarthritis Therapy Targeting NLRP3 Inflammasome: Progress From Mechanism to Application},
journal = {Immunity, Inflammation and Disease},
year = {2026},
doi = {10.1002/iid3.70520}
}
EUVIMED